Structure Therapeutics (GPCR) Shares Outstanding (2022 - 2026)

Structure Therapeutics' Shares Outstanding history runs 5 years deep, the most recent figure standing at $213.2 million for Q1 2026.

• In Q1 2026, Shares Outstanding rose 23.52% year-over-year to $213.2 million; the TTM figure through Mar 2026 stood at $213.2 million (up 23.52% YoY), while the FY2025 annual figure was $212.5 million, up 23.65% from the prior year.
• Shares Outstanding was $213.2 million for Q1 2026 at Structure Therapeutics, roughly flat from $212.5 million in the prior quarter.
• In the past five years, Shares Outstanding ranged from a high of $213.2 million in Q1 2026 to a low of $10.5 million in Q2 2022.
• Historically, Shares Outstanding has averaged $124.7 million across 5 years, with a median of $139.9 million in 2024.
• The sharpest annual moves came in 2023 and 2025: Shares Outstanding surged 1222.5% in 2023, then increased 0.65% in 2025.
• A 5-year view of Shares Outstanding shows it stood at $10.5 million in 2022, then soared by 1222.5% to $139.2 million in 2023, then gained by 23.44% to $171.9 million in 2024, then increased by 23.65% to $212.5 million in 2025, then advanced by 0.33% to $213.2 million in 2026.
• The last three Shares Outstanding figures came in at $213.2 million (Q1 2026), $212.5 million (Q4 2025), and $182.0 million (Q3 2025), per Business Quant data.